SCHEMBL23710567

SCHEMBL23710567

Nc1nc(=O)[nH]c2c1ncn2C[C@H](O)CO

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.51
AHCY P23526 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 2/20 0.40
POLB P06746 1/20 0.40
HPRT1 P00492 6/20 0.39
BLM P54132 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
CYP3A4 P08684 1/20 0.39
NFKB1 P19838 1/20 0.39
VCP P55072 1/20 0.39
KMT2A Q03164 1/20 0.39
HIF1A Q16665 1/20 0.39
ADORA1 P30542 2/20 0.37
ADORA2B P29275 1/20 0.37
TK1 P04183 2/20 0.36
USP2 O75604 1/20 0.36
PNP P00491 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24098412 0.80 HPRT1 (0.47) SMN1; SMN2LMNAHPRT1BLMALDH1A1
SCHEMBL24113799 0.77 CDK1 (0.50) ADORA2ASMN1; SMN2BLMKMT2AADORA1
SCHEMBL23710597 0.76 LMNA (0.36) ADORA2AAHCYSMN1; SMN2LMNAPOLB
SCHEMBL7142936 0.74 HPRT1 (0.67) SMN1; SMN2LMNAHPRT1BLMALDH1A1
SCHEMBL24420506 0.74 HPRT1 (0.67) SMN1; SMN2LMNAHPRT1BLMALDH1A1
SCHEMBL23710631 0.74 HPRT1 (0.67) SMN1; SMN2LMNAHPRT1BLMALDH1A1
SCHEMBL23710566 0.72 AHCY (0.68) ADORA2AAHCYALDH1A1ADORA1ADORA2B
SCHEMBL7147173 0.71 AHCY (0.45) ADORA2AAHCYSMN1; SMN2LMNAPOLB
Tiviciclovir SCHEMBL15531845 0.69 BLM (0.45) SMN1; SMN2LMNAHPRT1BLMALDH1A1
SCHEMBL23240596 0.69 XDH (0.31) PNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210238595-A1 MODIFIED RNA AGENTS WITH REDUCED OFF-TARGET EFFECT ALNYLAM PHARMACEUTICALS, INC. (US) 2021-08-05 US disclosed